跳至主要内容
临床试验/IRCT20200825048515N67
IRCT20200825048515N67尚未招募2 期

Investigating the effect of two different doses of mannitol on reducing creatine phosphokinase (CPK) in brain death patients planned for organ donation

Esfahan University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16 years 至 55 years(—)
性别
All

入选标准

  • Confirmation of the patient's brain death
  • Having the age of 16 to 55 years
  • Confirmation of the patient's eligibility for kidney donation by the relevant team
  • The presence of creatine phosphokinase greater than or equal to 5000 units per liter in the patient's initial test
  • Consent of the patient's companions to perform the transplant and participate in the study

排除标准

  • Having a pacemaker
  • Heart failure

研究者

相似试验